Czejka M J, Schüller J, Jäger W, Fogl U, Weiss C
Institute for Pharmaceutical Chemistry, University of Vienna, Austria.
Eur J Drug Metab Pharmacokinet. 1993 Jul-Sep;18(3):247-50. doi: 10.1007/BF03188803.
The blood plasma levels of 5-fluorouracil (5FU) after i.v. administration have been determined without and under the influence of 1, 5 or 9 million units (MU) preadministered interferon (IFN) in patients with gastrointestinal carcinoma. The co-administration of 9 MU IFN causes a doubled increase of the 5FU serum concentrations combined with a statistically significant change of the pharmacokinetics of 5FU for c0, AUC, Vd and Cltot (P < 0.005). A similar effect with distinctly increased serum concentrations could be observed for the preadministration of 5 mU IFN whereby c0 and AUC were elevated significantly (P < 0.05), but not Vd, Cltot and cd. The preadministration of 1 MU IFN also leads to higher plasma levels, but no changes in the pharmacokinetics of 5FU could be calculated (P > 0.05). A linear correlation between the IFN dose and the pharmacokinetic parameters c0 (R = 0.958), AUC0-120 (R = 0.948), Vd (R = 0.941) and Cltot (R = 0.963) of 5FU could be found (P < 0.05), but not for the coefficient of distribution and t1/2el. The results indicate that the pharmacokinetics of 5FU might be influenced by the preadministered IFN dose.
在胃肠道癌患者中,已测定静脉注射5-氟尿嘧啶(5FU)后在未使用以及在预先给予100万、500万或900万单位(MU)干扰素(IFN)影响下的血浆水平。预先给予900万MU IFN会使5FU血清浓度增加一倍,同时5FU的药代动力学参数c0、AUC、Vd和Cltot发生统计学显著变化(P < 0.005)。预先给予500万MU IFN可观察到类似效果,血清浓度明显升高,其中c0和AUC显著升高(P < 0.05),但Vd、Cltot和cd无变化。预先给予100万MU IFN也会导致血浆水平升高,但无法计算出5FU药代动力学的变化(P > 0.05)。可发现IFN剂量与5FU的药代动力学参数c0(R = 0.958)、AUC0 - 120(R = 0.948)、Vd(R = 0.941)和Cltot(R = 0.963)之间存在线性相关性(P < 0.05),但分布系数和消除半衰期无相关性。结果表明,5FU的药代动力学可能受预先给予的IFN剂量影响。